Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Market Vectors® Pharmaceutical ETF (PPH)

74.18
Delayed Data
As of Jul 29
 +0.24 / +0.32%
Today’s Change
57.00
Today|||52-Week Range
74.97
+15.42%
Year-to-Date

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors  US Listed Pharmaceutical 25 Index (the "Pharmaceutical Index"). The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Performance

1 month+5.20% 3 years+26.39%
3 months+4.15% 5 years--
1 year+22.77% Since inception+25.10%
Data through 07/30/2015

Quote Details

Previous close$73.94
Open day’s range-- – --
Net asset value (NAV)74.11 (07/29/2015)
Daily volume39,089
Average volume (3 months)63,683
Data as of 07/29/2015

Peer Comparisonvs. Health ETFs

 PPHCategory
Performance 5-yr return--+26.72%
Expense Gross exp ratio0.43%0.47%
Risk 5 year sharpe ratio--1.74
Net assets$377.8M$2.0B
Average market cap$90.8B$37.5B
Average P/E23.125.5
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
NVS Novartis7.61%
JNJ Johnson & Johnson6.80%
PFE Pfizer5.48%
AGN Allergan5.17%
ABBV AbbVie5.10%
SNY Sanofi4.99%
GSK GlaxoSmithKline4.98%
MRK Merck4.90%
NVO Novo Nordisk4.86%
BMY Bristol-Myers Squibb4.71%